Filing Details
- Accession Number:
- 0000950170-24-002572
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-05 17:54:35
- Reporting Period:
- 2024-01-03
- Accepted Time:
- 2024-01-05 17:54:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1661998 | Homology Medicines Inc. | FIXX | Pharmaceutical Preparations (2834) | 473468154 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1916155 | Paul Alloway | C/O Homology Medicines, Inc. One Patriots Park Bedford MA 01730 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-01-03 | 7,280 | $0.57 | 28,036 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of restricted stock units.
- The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.058 to $0.58. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 2.
Billionaire Hedge Funds
